Pre-operative prediction of residual disease after interval cytoreduction for epithelial ovarian cancer using HE4
- 1 October 2019
- journal article
- research article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 29 (8) , 1304-1310
Abstract
Background Presence of residual disease after cytoreductive surgery is an important negative prognostic factor for patients with advanced stage epithelial ovarian cancer. Surgery is of limited benefit when the diameter of residual disease is >1 cm. Residual disease is difficult to predict before surgery. The multivariate model Cancer Ovarii Non-invasive Assessment of Treatment Strategy (CONATS) index, based on serum biomarker HE4, age, and World Health Organization performance status, predicted no visible residual disease in patients undergoing primary cytoreductive surgery with an area under the curve (AUC) of 0.85. The AUC of predicting residual disease >1 cm was not reported, although this can be of importance for pre-operative decision making, especially in fragile patients. We tested this model for predicting residual disease >1 cm in patients undergoing interval cytoreduction. Methods We retrospectively included patients with advanced epithelial ovarian cancer who underwent interval cytoreduction between January 2010 and December 2017 in two tertiary centers in the Netherlands. HE4 was measured with electrochemiluminescence in pre-operative samples. The CONATS index was used to predict residual disease. AUCs were calculated to predict residual disease >1 cm. Results A total of 273 patients were included. Mean (SD) age was 64 (11) years. Median number of cycles of neoadjuvant chemotherapy was 3 (range 3–6) and the most common regimen used consisted of carboplatin and paclitaxel. Before interval cytoreduction, 19 patients (7%) showed complete response to chemotherapy, 251 patients (92%) showed partial response, and 3 patients (1%) showed stable disease at imaging. Following surgery, 232 patients (85%) had residual disease ≤1 cm and 41 patients (15%) had residual disease >1 cm. The AUC was 0.80 for predicting residual disease >1 cm. In patients ≥70 years of age the AUC was 0.82. Conclusion The CONATS index predicts surgical outcome after interval cytoreduction and is useful in counseling patients about the chance of whether an optimal interval cytoreduction can be achieved. This could be especially helpful in counseling elderly patients in whom surgery has a high risk of complications.Keywords
This publication has 33 references indexed in Scilit:
- Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer?Tumor Biology, 2014
- Diffusion-weighted magnetic resonance imaging evaluation of intra-abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinomaEuropean Radiology, 2013
- Can the preoperative HE4 level predict optimal cytoreduction in patients with advanced ovarian carcinoma?Gynecologic Oncology, 2013
- Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patientsGynecologic Oncology, 2013
- CA-125 cut-off value as a predictor for complete interval debulking surgery after neoadjuvant chemotherapy in patients with advanced ovarian cancerJournal of Gynecologic Oncology, 2013
- Thirty-Day Mortality After Primary Cytoreductive Surgery for Advanced Ovarian Cancer in the ElderlyObstetrics & Gynecology, 2011
- Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian CancerInternational Journal of Gynecological Cancer, 2011
- Primary Radical Surgery in Elderly Patients With Epithelial Ovarian CancerInternational Journal of Gynecological Cancer, 2010
- Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trialBritish Journal of Cancer, 2009
- Predictors of suboptimal surgical cytoreduction in women with advanced epithelial ovarian cancer treated with initial chemotherapyInternational Journal of Gynecological Cancer, 2008